Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies-Reference-Cited by-同舟云学术

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies

Published:2012-02-12 Issue:3 Volume:18 Page:382-384
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Lipson Doron,Capelletti Marzia,Yelensky Roman,Otto Geoff,Parker Alex,Jarosz Mirna,Curran John A,Balasubramanian Sohail,Bloom Troy,Brennan Kristina W,Donahue Amy,Downing Sean R,Frampton Garrett M,Garcia Lazaro,Juhn Frank,Mitchell Kathy C,White Emily,White Jared,Zwirko Zac,Peretz Tamar,Nechushtan Hovav,Soussan-Gutman Lior,Kim Jhingook,Sasaki Hidefumi,Kim Hyeong Ryul,Park Seung-il,Ercan Dalia,Sheehan Christine E,Ross Jeffrey S,Cronin Maureen T,Jänne Pasi A,Stephens Philip J

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.nature.com/articles/nm.2673.pdf

Reference20 articles.

1. Forbes, S.A. et al. Nucleic Acids Res. 39, D945–D950 (2011).

2. Lièvre, A. et al. Cancer Res. 66, 3992–3995 (2006).

3. Di Nicolantonio, F. et al. J. Clin. Oncol. 26, 5705–5712 (2008).

4. Wertz, I.E. et al. Nature 471, 110–114 (2011).

5. Turner, N., Tutt, A. & Ashworth, A. Curr. Opin. Pharmacol. 5, 388–393 (2005).

Cited by 749 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of pralsetinib in patients with RET fusion positive non–small cell lung cancer: An observational real world study;Lung Cancer;2024-10

2. Side Chain Investigation of Imidazopyridazine as a Hinge Binder for Targeting Actionable Mutations of RET Kinase;ACS Medicinal Chemistry Letters;2024-09-03

3. The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future Directions;Cancers;2024-08-19

4. Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: “Shadows and Fogs”;Cancers;2024-08-19

5. Novel therapeutic strategies targeting bypass pathways and mitochondrial dysfunction to combat resistance to RET inhibitors in NSCLC;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-08